•
Sep 30, 2021
Cassava Sciences Q3 2021 Earnings Report
Announced financial results for the third quarter ended September 30, 2021.
Key Takeaways
Cassava Sciences reported a net loss of $9.6 million, or $0.24 per share, for the third quarter ended September 30, 2021. Cash and cash equivalents were $241.5 million as of September 30, 2021.
Net loss for the third quarter was $9.6 million, or $0.24 per share.
Net loss for the same period in 2020 was $1.4 million, or $0.06 per share.
Cash and cash equivalents were $241.5 million as of September 30, 2021, with no debt.
An additional $22.0 million was used during the third quarter of 2021 for an all-cash purchase of an office complex in Austin, Texas.
Cassava Sciences
Cassava Sciences
Forward Guidance
Net cash use for operations for full-year 2021 is expected to be approximately $25 to $30 million.